These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 11593421

  • 1. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
    Pierantoni GM, Fedele M, Pentimalli F, Benvenuto G, Pero R, Viglietto G, Santoro M, Chiariotti L, Fusco A.
    Oncogene; 2001 Sep 27; 20(43):6132-41. PubMed ID: 11593421
    [Abstract] [Full Text] [Related]

  • 2. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G, Di Marcotullio L, Ristori E, Zani M, Crescenzi M, Scarpa S, Piaggio G, Vacca A, Peverali FA, Diana F, Screpanti I, Frati L, Gulino A.
    Cancer Res; 1999 May 15; 59(10):2484-92. PubMed ID: 10344762
    [Abstract] [Full Text] [Related]

  • 3. The serine/threonine kinase HIPK2 interacts with TRADD, but not with CD95 or TNF-R1 in 293T cells.
    Li X, Wang Y, Debatin KM, Hug H.
    Biochem Biophys Res Commun; 2000 Oct 22; 277(2):513-7. PubMed ID: 11032752
    [Abstract] [Full Text] [Related]

  • 4. FHL2 mediates p53-induced transcriptional activation through a direct association with HIPK2.
    Lee SW, Kim EJ, Um SJ.
    Biochem Biophys Res Commun; 2006 Jan 27; 339(4):1056-62. PubMed ID: 16343438
    [Abstract] [Full Text] [Related]

  • 5. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.
    Yamada D, Pérez-Torrado R, Filion G, Caly M, Jammart B, Devignot V, Sasai N, Ravassard P, Mallet J, Sastre-Garau X, Schmitz ML, Defossez PA.
    Oncogene; 2009 Jul 09; 28(27):2535-44. PubMed ID: 19448668
    [Abstract] [Full Text] [Related]

  • 6. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
    Giannini G, Kim CJ, Di Marcotullio L, Manfioletti G, Cardinali B, Cerignoli F, Ristori E, Zani M, Frati L, Screpanti I, Guilino A.
    Br J Cancer; 2000 Dec 09; 83(11):1503-9. PubMed ID: 11076660
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis.
    Ohtsu N, Nobuhisa I, Mochita M, Taga T.
    Exp Cell Res; 2007 Jan 01; 313(1):88-97. PubMed ID: 17064687
    [Abstract] [Full Text] [Related]

  • 8. Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival.
    Wiggins AK, Wei G, Doxakis E, Wong C, Tang AA, Zang K, Luo EJ, Neve RL, Reichardt LF, Huang EJ.
    J Cell Biol; 2004 Oct 25; 167(2):257-67. PubMed ID: 15492043
    [Abstract] [Full Text] [Related]

  • 9. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y, Xu Z, Lin S, Li Q, Rui H, Luo W, Zhou HM, Cheung PY, Wu Z, Ye Z, Li P, Han J, Lin SC.
    EMBO J; 2004 Nov 24; 23(23):4583-94. PubMed ID: 15526030
    [Abstract] [Full Text] [Related]

  • 10. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors.
    Tallini G, Dal Cin P.
    Adv Anat Pathol; 1999 Sep 24; 6(5):237-46. PubMed ID: 10472377
    [Abstract] [Full Text] [Related]

  • 11. Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction.
    Dai F, Yu L, He H, Chen Y, Yu J, Yang Y, Xu Y, Ling W, Zhao S.
    Biochem Biophys Res Commun; 2002 May 17; 293(4):1191-6. PubMed ID: 12054501
    [Abstract] [Full Text] [Related]

  • 12. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis.
    Tkachenko A, Ashar HR, Meloni AM, Sandberg AA, Chada KK.
    Cancer Res; 1997 Jun 01; 57(11):2276-80. PubMed ID: 9187132
    [Abstract] [Full Text] [Related]

  • 13. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V, Soddu S, Sacchi A, D'Orazi G.
    Oncogene; 2005 Aug 18; 24(35):5431-42. PubMed ID: 15897882
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.
    Scala S, Portella G, Fedele M, Chiappetta G, Fusco A.
    Proc Natl Acad Sci U S A; 2000 Apr 11; 97(8):4256-61. PubMed ID: 10759549
    [Abstract] [Full Text] [Related]

  • 15. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins.
    Fedele M, Bandiera A, Chiappetta G, Battista S, Viglietto G, Manfioletti G, Casamassimi A, Santoro M, Giancotti V, Fusco A.
    Cancer Res; 1996 Apr 15; 56(8):1896-901. PubMed ID: 8620511
    [Abstract] [Full Text] [Related]

  • 16. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
    Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML, Koseki H, Kitabayashi I.
    EMBO J; 2006 Sep 06; 25(17):3955-65. PubMed ID: 16917507
    [Abstract] [Full Text] [Related]

  • 17. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G, Di Carlo SE, Folgiero V, Avetrani P, Lazzari C, D'Orazi G, Brizzi MF, Sacchi A, Soddu S, Blandino G, Mottolese M, Falcioni R.
    Cancer Res; 2009 Jul 15; 69(14):5978-86. PubMed ID: 19567674
    [Abstract] [Full Text] [Related]

  • 18. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability.
    Gresko E, Möller A, Roscic A, Schmitz ML.
    Biochem Biophys Res Commun; 2005 Apr 22; 329(4):1293-9. PubMed ID: 15766567
    [Abstract] [Full Text] [Related]

  • 19. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
    Harada J, Kokura K, Kanei-Ishii C, Nomura T, Khan MM, Kim Y, Ishii S.
    J Biol Chem; 2003 Oct 03; 278(40):38998-9005. PubMed ID: 12874272
    [Abstract] [Full Text] [Related]

  • 20. A proline-rich domain in the gamma subunit of phosphodiesterase 6 mediates interaction with SH3-containing proteins.
    Morin F, Vannier B, Houdart F, Regnacq M, Berges T, Voisin P.
    Mol Vis; 2003 Sep 18; 9():449-59. PubMed ID: 14502124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.